“…Beyond their important regulatory functions in immune response, STAT3 and NFκB family members are ubiquitously expressed in most types of cancer and involved in tumorigenesis, progressions and metastasis 47,48 . Moreover, sepsis is significantly associated with increased risk for many cancers including chronic myeloid leukaemia, myelodysplastic syndrome, acute myeloid leukaemia, cancers of the cervix, liver, lung, rectum and colon 49 . To date, multiple NFκB inhibitors were evaluated in clinical to treat various cancer types including prostate, renal and colorectal cancers, melanoma and leukaemia whereas the JAK/STAT inhibitors were also tested for their anti‐cancer efficacy in ovarian, brain, prostate, pancreatic and neurologic cancers and multiple myeloma 6 .…”